ACQUISITION OF SANGAMO THERAPEUTICS FRANCE S.A.S. - (Tables)

3 Months Ended

Mar. 31, 2021

Business Combinations [Abstract]

Summary of Non-controlling Interest

Non-controlling interest as of March 31, 2021 was as follows (in thousands):

	Total
Balance at December 31, 2020	$	(868)
Fair value of additional shares acquired	(64)
Loss attributable to non-controlling interest	(6)
Balance at March 31, 2021	$	(938)